Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New AMPK activators presented by Skylark Bioscience

March 25, 2020

H. Lee Moffitt Cancer Center and Research Institute presents BRD4-JAK2 inhibitors

March 25, 2020

Roche and Genentech patent TEAD inhibitors

March 25, 2020

IND application for AG-946 cleared by FDA

March 25, 2020

USP28 regulates deltaNp63 protein abundance in squamous cell carcinoma and can be a druggable target

March 24, 2020

Ascentage doses first U.S. patient in global study of APG-2575 for relapsed/refractory CLL/SLL

March 24, 2020

New eiF4E inhibitors presented by Pic Therapeutics

March 24, 2020

Birdie Biopharmaceuticals discloses new imidazoquinoline derivatives

March 24, 2020

Researchers identify lncRNA RPL34-AS1 as potential therapeutic target in esophageal cancer

March 24, 2020

European Commission approves intravenous formulation of Akynzeo

March 24, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...